| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methoxy-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_080658.2 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 91703 |
| UniProt ID | Q96HD9 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methoxy-UTP |
| 5' Cap | Cap 1 |
| Species | Human |
| RefSeq | NM_080658.2 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 91703 |
| UniProt ID | Q96HD9 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACY3, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) (GTTS-WK13381MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK1894MR | IVTScrip™ mRNA-Human CD13, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) | mRNA | CD13 |
| GTTS-WK18347MR | IVTScrip™ mRNA-Human AK2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | AK2 |
| GTTS-WK17110MR | IVTScrip™ mRNA-Human AGPAT4, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) | mRNA | AGPAT4 |
| GTTS-WK14810MR | IVTScrip™ mRNA-Human ALDOC, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | ALDOC |
| GTTS-WK27828MR | IVTScrip™ mRNA-Human ASS1, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) | mRNA | ASS1 |
| GTTS-WK4456MR | IVTScrip™ mRNA-Human CD45RO, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) | mRNA | CD45RO |
| GTTS-WK23694MR | IVTScrip™ mRNA-Human ATP5A1, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) | mRNA | ATP5A1 |
| GTTS-WK3904MR | IVTScrip™ mRNA-Human VASA, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | VASA |